Research programme: Cannabinoid glycoside prodrugs - Graphium Biosciences
Latest Information Update: 12 Jan 2022
At a glance
- Originator Graphium Biosciences
- Class Anti-inflammatories; Cannabinoids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gastrointestinal disorders